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Small, carboxymethyl-starch-stabilised zinc oxide nanoparticles with a defined shape, size and morphology were prepared in situ in 
water at relatively low reaction temperatures using soluble carboxymethyl starch (CMS) as a combined crystallising, stabilising and 
solubilising agent and triethanolamine as the reducing agent. Aqueous colloidal solutions of these CMS-stabilised ZnO nanoparticles 10 
were used to deposit a coating of ZnO nanoparticles on cellulose paper by a wet-chemistry, polyelectrolyte, layer-by-layer approach 
using water as the only solvent. Such cellulose paper samples, coated with these CMS-stabilised ZnO nanoparticles, show higher 
brightness and whiteness than that of blank reference paper and are more stable to UV-radiation than the paper reference as well as 
demonstrating good antibacterial activity against MRSA and A. baumannii.  
 15 
1. Introduction 
  Zinc oxide (ZnO), an n-type semiconductor with wide band 
gap (3.37 eV)[1] and binding energy (60 meV) [2], has attracted 
significant interest because of its excellent electrical, optical and 
chemical properties[3]. Nanosized ZnO can be utilized in 20 
electrodes [4], optics [5], optoelectronics[6], sensors[7], and light-
emitting diodes [8]. ZnO nanoparticles also exhibit excellent UV 
protection and antibacterial activity[9 – 12 ]. It has been reported 
that ZnO nanoparticles have selective toxicity to bacteria, but 
exhibit a minimal effect on human cells, which is important 25 
taking into account the increasing presence of nanoparticles in the 
environment.[13 – 16]  Studies have also shown that the 
nanoparticle size and morphology play pivotal roles in 
determining the antibacterial activities of ZnO powders – 
antibacterial activity increases with increasing surface area and 30 
decreasing nanoparticle size[13, 17, 18].  
  Many different physical and chemical synthetic approaches 
have been developed to prepare ZnO nanoparticles, with regard to 
controlling the morphology, size and shape.[19 – 21] Compared with 
physical methods, chemical methods, such as precipitation and 35 
sol-gel approaches, have shown some distinct advantages for the 
synthesis of ZnO nanoparticles, including easy scale-up, low 
reaction temperature and inexpensive equipment.[22] The 
synthesis is generally carried out in alcohol using zinc salts such 
as Zn(ClO4)2, Zn(NO3)2 or Zn(Ac)2·H2O as starting materials in 40 
the presence of a base such as NaOH and LiOH. However, alkali 
ions (Li+ or Na+) doped in ZnO affects electrical and 
luminescent properties dramatically. Thus, much effort has been 
expended in an attempt to purify the final materials by removing 
the alkali ions through washing.[23] At the same time, many new 45 
processes, without addition of base, have also been developed to 
avoid this problem.[22, 24, 25] Another problem generally occurring 
with the chemical synthetic methods is the aggregation of 
nanoparticles in solution in order to minimize surface energy. 
This aggregation can be prevented or inhibited by the formation 50 
of self-assembled monolayers with synthetic polymers and 
surfactants on the nanoparticle surface during the synthesis.[26, 27, 
28]  
 Recently, cellulose derivatives, including starch, have been 
developed as a crystallising and stabilising agent to control the 55 
shape, size and size distributions of ZnO nanoparticles.[25, 29, 30, 31] 
Along with their traditional applications in paper and cotton 
textiles, cellulose derivatives are also very important, 
environmentally friendly, biocompatible, sustainable and cost-
effective, sources of carbon-based polymers and substrates for the 60 
development of sophisticated nanocomposite materials.[32] 
Cellulose is a extensive, linear, mainchain polysaccharide 
consisting of repeating -D-glucopyranose moieties covalently 
linked through acetal functions between the equatorial OH 
groups. The presence of this very large number of hydrophilic 65 
hydroxyl groups [33, 34] promotes the nucleation and growth of 
inorganic phases at the cellulose fibre surface, which in turn can 
facilitate the production of cost-effective organic/inorganic 
nanocomposites.[35, 36, 37]  
 Protection of cellulose-based materials against different kinds 70 
of degradation, such as photochemical and bacterial degradation, 
and the creation of functional surfaces could be realised by the 
presence of a functional nanoparticle coating. Small ZnO 
nanoparticles are much less photocatalytically active than the 
corresponding TiO2 nanoparticles of a similar size and shape and 75 
so do not photo-degrade the polysaccharide coating or cellulose 
substrate, such as textiles, bandages, etc, as similar TiO2 
nanoparticles might well do. Small, spherical ZnO nanoparticles 
   
are very efficient absorbers of UV light and can exhibit 
pronounced antibacterial activity.[9, 10] Surprisingly, there appears 
to be a limited number of reports of functional ZnO 
nanoparticle/cellulose nanocomposites. Ling et al reported the 
deposition of commercial ZnO nanoparticles (d ~ 20 nm) on the 5 
surface of paper, by an ultrasound-assisted method, which 
possesses antibacterial activity against Escherichia Coli 11634. 
[38] Rod-shaped ZnO particles were reported to grow in situ on 
cellulose fibres using a two-step process, i.e., formation of ZnO 
seeds on a fibre surface and then growth of the seeds into larger 10 
particles by controlled hydrolysis of Zn(II)-amine complexes. [30] 
ZnO-nanoparticle coated papers, with good anti-fungal and UV-
protecting properties, were also prepared using a pigment slurry 
containing a dispersant, china clay and starch-stabilized ZnO 
nanoparticles (prepared using zinc nitrate and sodium hydroxide 15 
as precursors).[29]  
 Carboxymethyl starch (CMS) is a cellulose derivative with 
carboxymethyl groups (-CH2-COOH) bound to the 
polysaccharide backbone. The polar carboxyl groups render CMS 
more resistant to heat and bacteria and also more hydrophilic, i.e., 20 
more water soluble, than starch. CMS is a cheap, renewable 
resource that is used commercially in food science as a viscosity 
modifier or thickener and to stabilize emulsions in various 
products. Therefore, we decided to investigate the use of CMS to 
prepare novel, water-soluble CMS-stabilised ZnO nanoparticles. 25 
We wished to evaluate them as a functional, protective coating 
for cellulose fibres deposited using a combination of a simple, 
dip-coating technique and an efficient wet-chemistry 
polyelectrolyte layer-by-layer paper coating process,[39, 40, 41] both 
of which use water as the solvent. No impact or spray coating 30 
techniques, chemical binders, surfactants, dispersants or a post-
treatment curing step are required. The CMS-stabilised ZnO 
nanoparticles are prepared in a simple fashion using water as the 
solvent at relatively low temperatures using triethanolamine as 
the reducing agent and CMS as a combined crystallising, 35 
stabilising and solubilising agents. A much lower loading of 
nanoparticles is required using this surface-based approach than 
dispersing nanoparticles in the bulk fibre mixtures used to 
prepare paper, fabrics, textiles, etc., which is advantageous in 
terms of minimising contamination of the environment with 40 
nanoparticles.  
 This approach could facilitate the mass manufacture of lighter 
sheets of printer paper, for example, which would represent a 
significant saving in the enormous amounts of pulp used in paper 
manufacture, be much more energy efficient and produce less 45 
contaminated waste water.[41] It could also have a significant 
impact on minimising the transfer of multidrug resistant bacteria, 
such as methicillin-resistant Staphylococcus aureus (MRSA), 
which is a constituent part of the natural flora of the human body, 
between patients in a hospital environment. Staphylococcus 50 
aureus is as an opportunistic pathogen responsible for serious 
infections, which can often be treated with broad-spectrum 
antibiotics, such as oxacillin.[30] However, some bacteria are 
becoming ever more resistant to many types of organic 
antibiotics, particularly -lactams, which can lead to much more 55 
extensive hospital stays and even, in some cases, to death.[31] 
Therefore, the prevention of infections caused by multidrug 
resistant bacteria, such as MRSA, could reduce patient mortality 
and associated treatment costs. Antibacterial coatings of small 
ZnO nanoparticles with a large active surface area on cellulose 60 
bandages, uniforms and bed linen, for example could make a 
significant contribution to reducing bacterial transfer and also 
preventing injury- or elective surgery-related wound infections. 
 
2. Experimental 65 
2.1. Materials and characterization methods 
  The experiments were performed using the following chemical 
substances: zinc nitrate hexahydrate Zn(NO3)2·6H2O, 
triethanolamine, poly(diallydimethylammonium chloride) 
(PDDA, 20 wt% in water, MW 100,000 – 200,000) and 70 
poly(sodium 4-styrenesulfonate) (PSS, MW 70,000) were 
supplied by Aldrich and used as received. Carboxymethyl starch 
(CMS, MW 5,000,000) was provided by TiTk, Germany. 
Ultrapure water with the specific resistance of 18.2 MΩ·cm was 
obtained by reversed osmosis followed by ion-exchange and 75 
filtration (UPQ PS system, ELGA, USA). The Mondi cellulose 
papers which are 1 mm thick were provided by Mondi group.  
    Scanning electron microscopy (SEM) images were obtained 
using Carl Zeiss SMT ‘EVO60’ SEM microscope operating at 20 
kV and EDX data were obtained using an Oxford Instruments 80 
‘INCA’ Energy Dispersive X-ray Spectrometer. Transmission 
electron microscopy (TEM) was collected using a Jeol 2010 TEM 
running at 200 kV. Images were obtained with a Gatan Ultrascan 
4000 digital camera. Solid samples were prepared by suspension 
in distilled water and 5 µL aliquots of a suitable dilution dropped 85 
onto carbon coated copper grids. Thermogravimetric analyses 
(TGA) were performed on a Netzsch TGA TG209 thermal 
balance. The amounts of zinc were determined by an inductively 
coupled Perkin Elmer plasma 40 emission ICP instrument. X-ray 
powder diffraction (XRD) analysis was carried out using a 90 
SIEMENS D5000 Instrument. The nanoparticle size was 
estimated by using the Scherrer equation, [42] Dh,k,l = 0.89/cos, 
where D is the crystallites size,  the X–ray wavelength used, 
0.154 nm,  the broadening of the diffraction line measured at 
half of its maximum intensity (FWHM) and , the corresponding 95 
angle. The whiteness was measured with a standard whiteness 
tester (Lorentzen & Wettre, Elrepho). Brightness was determined 
using a Suntest XLS+ instrument from ATLAS Material Testing 
Solutions (90 min at 500 W and at 2700 kJ m-2). 
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2.2. Aqueous colloidal solutions of CMS-stabilised ZnO 
nanoparticles 
 
  The synthesis of ZnO nanoparticles in the presence of 105 
carboxymethyl starch was performed as follows. Zn(NO3)2·6H2O 
(0.44 g) was first dissolved in water (10 mL), CMS solution 
(0.2%, 90 mL) was added slowly under stirring to the reaction 
mixture, which was then heated at 90 C for 3 h. Triethanolamine 
was then added and the reaction mixture was heated at 90 C for 110 
a period of either 3 or 20 h. After cooling in ice, in order to stop 
the reaction quickly, the reaction mixture was centrifuged at 
10,000 rpm for 15 min. The isolated CMS-stabilised ZnO 
nanoparticles were washed three times with distilled water, in 
order to remove by-products and excess soluble CMS, and then 115 
   
dried under vacuum overnight.  
 
2.3. Coating of cellulose paper with CMS-stabilised ZnO 
nanoparticles  
  Firstly, two aqueous solutions of polyelectrolytes were 5 
prepared, i.e., 1% (wt/v) of PDDA in 0.5 M NaCl and 1% (wt/v) 
of PSS in 0.5 M NaCl. Samples of cellulose paper were then 
immersed (10 min) first in the PDDA solution, then in the PSS 
solution and finally again in the PDDA solution. After each 
immersion step, the cellulose paper samples were washed with 10 
water and dried under vacuum. Aqueous colloidal solutions of 
CMS-stabilised ZnO nanoparticles were prepared by adding 
ZnO/CMS (100 mg) nanoparticles to distilled water (12 mL) and 
the resultant mixtures sonicated for 15 min. Then, the 
PDDA/PSS/PDDA-treated cellulose paper samples (~ 0.6 g) were 15 
immersed in the colloidal solutions of CMS-stabilised ZnO 
nanoparticles at room temperature and then sonicated for a further 
15 min. The ZnO/CMS-coated paper samples were then washed 
with water and dried under vacuum overnight. 
 20 
2.4. Antibacterial properties of cellulose paper coated with 
CMS-stabilised ZnO nanoparticles  
  The antibacterial properties of colloidal solutions of CMS-
stabilised ZnO nanoparticles and those of the corresponding 
cellulose paper samples, with a coating of identical CMS-25 
stabilised ZnO nanoparticles, were assessed using diffusion and 
microtitre assays against bacterial isolates. Isolates of 
Pseudomonas aeruginosa (Clinical isolate PA3 from blood) and 
Burkholderia cenocepacia (Clinical isolate BCC1 from cerebral 
spinal fluid) were identified via biochemical profiling with API-30 
20NE (BioMerieux, La Balme Les Grottes, France) and MALDI-
TOF mass-spectrometry (Bruker, Coventry, UK).and obtained 
from the Health Protection Agency laboratories, Colindale, UK. 
Type strains of methicillin resistant Staphylococcus aureus 
(NCTC 12493), Acinetobacter baumannii (NCTC 12156) 35 
purchased from Pro-lab diagnostics, Wirral, UK and 
Stenotrophomonas maltophilia (NCTC 10258) purchased from 
the Health Protection Agency laboratories, Porton Down, UK. 
These isolates were chosen due to their resistance to antibiotics 
and their ability to cause serious skin and wound infections and 40 
infections associated with invasive devices such as catheters and 
intravenous lines (IV). All media was purchased from Oxoid, 
Basingstoke, UK and autoclaved prior to its use.  
  The antibacterial activity of aqueous colloidal solutions of the 
CMS-stabilised ZnO nanoparticles against all bacterial isolates 45 
was determined using a microtitre assay. Stock aqueous solutions 
of the CMS-stabilised ZnO nanoparticles were prepared by the 
addition of 4 mg of ZnO powder to sterile distilled water (10 
mL). Solutions were shaken and then sonicated for 15 mins to 
form stable, aqueous colloidal solutions. Double dilutions of the 50 
stock solutions were performed in IsoSensitest broth before 
samples (100 µL) of each concentration were pipetted into 
individual microtitre wells. A 100 µL sample of broth, containing 
the bacterial inoculums (106 colony forming units [CFU]/mL) 
taken and diluted from 6 h cultures (Stationary phase of growth), 55 
was then added to each well. The final well concentration of the 
CMS-stabilised ZnO nanoparticles ranged from between 200 and 
0.195 µg/mL. All the microtitre plates were incubated at 37 °C 
for 24 h before being checked for the presence of bacterial 
growth. A solution of 0.2% CMS in water was used as a control. 60 
 Iso-Sensitest agar plates were individually inoculated with 
isolates of MRSA (NCTC 12493) and A. baumannii (NCTC 
12156) using the standardized method by Moosdeen et al.[43] 
Paper samples coated with the ZnO nanoparticles or 
PDDA/PSS/PDDA coated control papers were added to 65 
individual inoculated agar plates (106 CFU/mL), which were then 
incubated at 37 C for 24 hours. Three replicate experiments were 
performed for each agar plate in order to confirm the results.  
 The antibacterial activity of the cellulose paper samples 
coated with or CMS-stabilised ZnO nanoparticles were evaluated 70 
using a method based on that by Pollini et al. [44] Antibacterial 
action was rated “good” (zone of inhibition > 1 mm), “fairly 
good” (zone of inhibition ≤ 1 mm), “sufficient” (growth up to, but 
not on, the paper sample), “limited” (limited growth on the paper 
sample) or “poor” (paper sample is overgrown with bacteria ≥ 50 75 
%).  
   
3. Results and discussions 
3.1. Preparation of CMS-stabilised ZnO nanoparticles  
  Dissolving CMS (0.2%) in hot water under stirring 80 
gives a solution with a high viscosity. No colloidal solution forms 
after heating of the Zn(NO3)2·6H2O – CMS solution at 90 C for 
3 h. The solution only then turns into a colloidal solution after the 
addition of triethanolamine. A white, milky colloidal solution is 
obtained after reaction at 90 C for 3 h. However, the colloidal 85 
solution is not very stable as evidenced by the formation of 
precipitates upon standing at 0 C over night. After centrifuging, 
washing and drying, a white sponge (0.084 g) was obtained. XRD 
analysis indicates the formation of cubic ZnO, with an average 
nanoparticle size of about 10 nm (Figure 1). However, reaction at 90 
20 h gives a white powder, which has a similar XRD pattern to 
that of the sample prepared by heating for 3 h. The IR spectra of 
both samples are the same as that of CMS itself, indicating the 
formation of ZnO/CMS nanocomposites (Figure 2). TGA curves 
of both samples show that the main reduction in mass occurs at 95 
300 – 440 C due to the decomposition of CMS. The amount of 
residue at 800 ˚C is 74.7 and 83.6% for the CMS-stabilised ZnO 
nanoparticles prepared by heating for 3 h or 20 h, respectively, 
suggesting that the content of carboxymethyl starch present in the 
composite decreases with increasing reaction time (Figure 3). 100 
TEM images also show the formation of large (d ~500 nm) 
ZnO/CMS granules (Figure 4) composed of numerous small, 
spherical CMS-stabilised ZnO nanoparticles (d ~ 10 nm). It can 
also be noticed from the TEM images that the particles of 
ZnO/CMS-20h are more compact than those of ZnO/CMS-3h due 105 
to less of CMS presence in the particles. The large granules with 
particle size of 500 ± 50 nm for ZnO – 20h and 550 ± 50 nm for 
ZnO – 3h are also observed in the corresponding SEM images 
(Figure 5). The formation of aggregated large particles in 
polysaccharides solution, such as starch solution, has also been 110 
reported because polysaccharides have high number of 
coordinating functional groups.[25] When Zn(NO3)2 was added to 
the CMS solution and heated at 90 ˚C for 3 h,  the zinc ions are 
probably closely associated with the CMS molecules. Thus, 
nucleation and initial crystal growth may preferentially occur 115 
within regions of both high CMS and Zn2+ concentration, leading 
   
to the formation of about 10 nm nanoparticles in order to reduce 
the high surface area as is often the case for nanoparticles. In a 
further step, they aggregate and form larger spherical CMS-
stabilised ZnO nanoparticles. In this system, the CMS probably 
acts both as a flocculant and facilitator of nanoparticle 5 
aggregation.[25] 
 
 
 
 10 
Fig. 1 XRD patterns of ZnO/CMS prepared at 90 C for 3 h (a) 
and 20 h (b). 
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Fig. 2 IR spectra of (a) ZnO, (b) CMS and ZnO/CMS 
nanoparticles prepared at 90 C for 3 h (c) and 20 h (d). 
 20 
 
 
Fig. 3 TGA of (a) CMS and (b & c) ZnO/CMS nanoparticles 
prepared at 90 C at different times (b) 3h and (c) 20 h. 
 25 
 
Fig. 4 TEM image of the CMS-stabilised ZnO nanoparticles and 
aggregates prepared at 90 C for 3 h (a, b and c) and 20 h (d, h 
and f). 
 30 
Fig. 5 SEM image of the CMS-stabilised ZnO nanoparticles and 
aggregates prepared at 90 C for 20 h (a) and 3 h (b).  
3.3. Coating of cellulose paper with CMS-stabilised ZnO 
nanoparticles  
   
  Cellulose fibres are normally negatively charged over a wide 
pH range, due to the presence of ionisable moieties, such as 
carboxyl or hydroxyl groups. CMS-stabilised ZnO nanoparticles, 
in contact with neutral aqueous solutions, are also negatively 
charged. Therefore, we have developed a Layer-by-Layer 5 
procedure to induce a positive charge on the surface of cellulose 
paper samples in order to facilitate the coating and fixing of these 
samples with CMS-stabilised ZnO nanoparticles making use of 
strong coulombic interactions.  
  The XRD spectra of the cellulose paper samples coated with 10 
ZnO/CMS nanoparticles (Figure 6) show peaks attributable to 
cubic ZnO in addition to a strong peak at 23  attributable to 
cellulose itself. SEM images of the ZnO/CMS coated cellulose 
papers clearly show that nearly no CMS-stabilised ZnO particles 
have been deposited on the cellulose fibres, if the paper surfaces 15 
have not been treated first using the Layer-by-Layer procedure 
(Figure 7). In contrast CMS-stabilised ZnO nanoparticles are seen 
to have been deposited and fixed on LBL-treated paper surfaces 
and are not removed by repeated washing with copious amounts 
of water. A relatively homogenous coating of CMS-stabilized 20 
ZnO nanoparticles can be observed on the LBL-treated paper 
surfaces in the SEM images (Figure 7). The loading of ZnO on 
the paper samples is 2.73 and 3.83% for the cellulose papers 
coated with CMS-stabilized ZnO nanoparticles prepared at 90 C 
for 3 and 20 h, respectively.  25 
 
 
 
Fig. 6 XRD patterns of the cellulose paper samples coated with 
ZnO/CMS nanoparticles prepared at different reaction times (a) 3 30 
h and (b) 20 h. 
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Fig. 7 SEM images of ZnO/CMS coated cellulose papers. (a, d, 
g) samples without an LBL treatment, but with immersion in a 
colloidal solution of CMS-stabilized ZnO nanoparticles prepared 40 
at 90 C for 20 h. All the other samples have been treated using a 
LBL approach followed by immersion in colloidal solutions of 
CMS-stabilized ZnO nanoparticles prepared at different reaction 
times. (b, e, h) 3 h and (c, f, i) 20 h.  
 45 
    
  
 
 
Fig. 8 (a) Brightness and (b) CIE whiteness of the blank paper 50 
reference and ZnO/CMS-nanoparticle-coated paper samples 
before and after UV-illumination from the xenon source. 
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 The ISO-brightness and CIE whiteness of blank reference paper 
and the paper samples coated with a thin layer of ZnO/CMS 
nanoparticles, before and after the xenon UV-stability test, are 
shown in Figure 8. It can be seen that both the brightness and 
whiteness of the samples of cellulose paper coated with CMS-5 
stabilised ZnO nanoparticles are both higher than the 
corresponding values determined for the blank paper reference.  
3.4 Antibacterial activity of the or CMS-stabilised ZnO 
coated cellulose paper samples and colloid solutions 
 Results from the microtitre assays for the two CMS-stabilised 10 
ZnO nanoparticle samples, ZnO/CMS-3 and ZnO/CMS-20, 
indicate that each of these aqueous colloidal solutions 
demonstrate an antibacterial activity against all of the bacterial 
isolates tested (Table 1), with the exception of ZnO/CMS-3 
against S. maltophilia (NCTC 10258), where concentrations ≥200 15 
µg/mL of both ZnO/CMS samples were required to induce 
inhibition of bacterial growth. The highest activity was observed 
against P. aeruginosa, where inhibition is seen at concentrations 
of 25 – 50 µg/mL. As expected the CMS control solution was 
found to have no antibacterial effect and actually resulted in 20 
increased bacterial growth at 0.2% compared with lower 
concentrated dilutions. The antibacterial activity of the cellulose 
paper samples coated with CMS-stabilised ZnO nanoparticles 
against MRSA and A. baumannii are shown in Table 2.  
 25 
Table 1. Minimum inhibitory concentrations of aqueous colloidal 
solutions of CMS-stabilised ZnO nanoparticle against bacterial 
isolates (µg/mL) 
 
Bacterial Isolate 
 
ZnO/CMS-3  ZnO/CMS-20 CMS solution 
P. aeruginosa (PA3) 50 50 No effect 
B. cenocepacia (BCC1) 50 100   No effect 
MRSA (NCTC 12493) 100 100 No effect 
S. maltophilia (NCTC 10258) >200 200 No effect 
A. baumannii (NCTC 12156) 100 200 No effect 
  30 
ZnO/CMS-3 and -20 samples are paper samples coated with 
CMS-stabilized ZnO nanoparticles prepared at 90 ˚C for 3 and 20 
h, respectively. It can be been seen that ZnO/CMS/CP-20 exhibits 
a more significant antibacterial effect against MRSA than that of 
ZnO/CMS/CP-3 (Table 2). There is a clear antibacterial effect 35 
against MRSA for the paper sample treated with ZnO/CMS/CP-
20 with a clear zone of inhibition (Figure 9). Against A. 
baumannii there appeared to be no significant difference in 
antibacterial action between ZnO/CMS/CP-3 and -20. Control 
papers coated only with PDDA/PSS/PDDA were found to have 40 
no antibacterial effect with bacterial growth occurring up to and 
on the papers. 
 
 
 45 
 
 
 
 
Table 2. Antibacterial activity and zones of inhibition of 50 
cellulose paper samples coated with CMS-stabilised ZnO 
nanoparticles against isolates of meticillin resistant 
Staphylococcus aureus (MRSA) NCTC 12493 and Acinetobacter 
baumannii NCTC 12156. 
 55 
ZnO Sample 
Bacterial isolate 
MRSA A. baumannii 
 
ZnO/CMS/CP-3 
 
Fairly good (1 mm ± 0.5) 
 
Fairly good (1 mm ± 0.5) 
ZnO/CMS/CP-20 Good (5 mm ± 0.5) Fairly good (1 mm ± 0.5) 
PDDA/PSS/PDDA 
Control 
Poor (0 mm ± 0) Poor (0 mm ± 0) 
Zones of inhibition are presented as the diameter of the area of no bacterial growth, minus 
the diameter of the paper itself. 
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Fig. 9 Antibacterial effect of ZnO/CMS/CP-20 paper against 
MRSA NCTC 12493. 
 
     The ZnO/CMS-20 paper was washed with ethanol after the 65 
antibacterial test to remove bacteria (dead or living) and then 
checked again using SEM analysis. No significant difference in 
ZnO nanoparticle size can be observed when comparing the SEM 
images before and after the antibacterial test (see support 
information). That means that the ZnO/CMS particles are quite 70 
stable during the antibacterial test and after the ethanol washing 
process.  
  Potential mechanisms involved in the antibacterial activity of 
the CMS-stabilised ZnO nanoparticles include production of 
reactive oxygen species (ROS), which are highly reactive 75 
chemical agents, and which contain oxygen, e.g., H2O2. These 
agents are formed in the presence of ZnO nanoparticles and they 
can result in damage to bacterial DNA and cell membranes (lipid 
peroxidation) and protein dysfunction. The release of zinc ions is 
proposed as a mechanism of the antimicrobial action of 80 
nanoparticles in this work. Zinc ions released from nanoparticles 
can interact with thiol groups on essential bacterial enzymes, 
resulting in their inactivation and consequently leading to cell 
death. Another potential mode of action is through impaired 
membrane function, which is thought to be due to electrostatic 85 
6 mm 
   
interaction of ZnO nanoparticles and the surface of the bacteria 
resulting in ZnO nanoparticle aggregation on the cell surface and 
changes in cell morphology, leading to significant cell growth 
inhibition.[45] All the proposed mechanisms have greater potency 
in ZnO nanoparticles than ZnO macroparticles/solid zinc due to 5 
the nanoparticles increased surface area and reactivity, resulting 
in greater interactions with cells and the release of higher 
concentrations of zinc ions. The mechanism behind the 
resistance, or lower susceptibility, to ZnO nanoparticles of S. 
maltophilia (NCTC 10258) could include the active efflux of the 10 
ZnO nanoparticles from the bacterium and a reduced uptake due 
to a reduced number of membrane transporters.[46]  
 
 
Several explanations could account for the lower antimicrobial 15 
effect of ZnO/CMS-20 than ZnO/CMS-3 against B. cenocepacia 
and A. baumannii. Although ZnO/CMS-20 solutions have a 
greater number of nanoparticles, the amount of CMS per 
nanoparticle is less as shown by TGA analysis, resulting in more 
compact groups of nanoparticles and reduced interaction with the 20 
surface if the bacterial cells. Another explanation could be that 
the increased number of nanoparticles in ZnO/CMS-20 could 
trigger increased active efflux in these bacteria resulting in lower 
concentrations of ZnO within the bacterial cells. Future work 
should investigate the actual mechanisms behind the variances in 25 
antimicrobial effect of ZnO nanoparticles between different 
bacterial species 
 
The concentrations of CMS-stabilised ZnO nanoparticles required 
to inhibit bacterial growth are relatively high, when compared to 30 
that of most conventional antibiotics. However, the potential for 
using aqueous colloidal solutions of or CMS-stabilised ZnO 
nanoparticles in a medical setting is high, as they could be used 
topically or as coatings for bandages, beddings, uniforms and 
medical devices, for example, at a low overall concentration. 35 
 It should be noted that although ZnO is an effective 
antimicrobial agent, that they would not be suitable to use against 
bacterial isolates, which produce the metallo-β-lactamase 
enzymes and which sequester zinc for use in degrading beta-
lactam antibiotics. The use of ZnO would increase the likelihood 40 
of antibiotic treatment failure. In this case an alternative metal 
nanoparticle, such as silver, would be more appropriate.  
 
4. Conclusions 
  Spherical, carboxymethyl-starch-stabilised ZnO nanoparticles 45 
with a cubic crystal structure were prepared in situ in water at 
relatively low reaction temperatures using water-soluble 
carboxymethyl starch (CMS) as a combined crystallising, 
stabilising and solubilising agent and triethanolamine as the 
reducing agent. The CMS-stabilised ZnO nanoparticles can be re-50 
dispersed in water to create stable aqueous colloidal solutions, 
which can then be used to deposit a coating of CMS-stabilised 
ZnO nanoparticles on the surface of samples of cellulose paper by 
a wet-chemistry polyelectrolyte layer-by-layer approach. 
Compared with a blank paper reference, the ZnO/CMS-coated 55 
paper samples show higher brightness and whiteness and a 
greater stability under UV-illumination than those of the 
reference and also good show antibacterial activity against 
MRSA and A. baumannii.  
 60 
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